Fundación Santiago Dexeus Font
Quick facts
Marketed products
- Cellular Matrix / A-CP-HA Kit · Regenerative Medicine / Orthopedics
A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair. - Ovarian Stimulation with CC+rFSH · Reproductive Medicine / Fertility
CC+rFSH is a combination hormonal therapy that stimulates ovarian follicle development by blocking negative feedback (clomiphene citrate) while directly stimulating follicle growth (recombinant FSH). - Ovarian Stimulation with rFSH · Reproductive Medicine / Fertility
Recombinant follicle-stimulating hormone (rFSH) stimulates the growth and maturation of ovarian follicles to produce multiple eggs for assisted reproductive procedures. - Ovulation triggering with GnRH-a
- Ovulation triggering with GnRH-a+rhCG · Reproductive Medicine / Fertility
GnRH agonist priming followed by recombinant human chorionic gonadotropin (rhCG) triggers final oocyte maturation and ovulation in assisted reproductive technology cycles. - rhFSH · Reproductive Medicine / Fertility
rhFSH (recombinant human follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women by binding to FSH receptors on granulosa cells. - rhFSH+rhLH · Reproductive/Fertility
rhFSH and rhLH are recombinant human gonadotropins that stimulate follicle development and ovulation in women undergoing fertility treatment.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: